Diamedica Therapeutics Stock Market Value
| DMAC Stock | USD 5.34 0.32 5.65% |
| Symbol | DiaMedica |
DiaMedica Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DiaMedica Therapeutics. If investors know DiaMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DiaMedica Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.56) | Return On Assets (0.24) | Return On Equity (0.35) |
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DiaMedica Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DiaMedica Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DiaMedica Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
DiaMedica Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DiaMedica Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DiaMedica Therapeutics.
| 12/14/2022 |
| 12/03/2024 |
If you would invest 0.00 in DiaMedica Therapeutics on December 14, 2022 and sell it all today you would earn a total of 0.00 from holding DiaMedica Therapeutics or generate 0.0% return on investment in DiaMedica Therapeutics over 720 days. DiaMedica Therapeutics is related to or competes with Milestone Pharmaceuticals, Seres Therapeutics, Inhibikase Therapeutics, Oncolytics Biotech, Scpharmaceuticals, Lyra Therapeutics, and Centessa Pharmaceuticals. DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney... More
DiaMedica Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DiaMedica Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DiaMedica Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.5 | |||
| Information Ratio | 0.1139 | |||
| Maximum Drawdown | 14.14 | |||
| Value At Risk | (3.46) | |||
| Potential Upside | 6.41 |
DiaMedica Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DiaMedica Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DiaMedica Therapeutics' standard deviation. In reality, there are many statistical measures that can use DiaMedica Therapeutics historical prices to predict the future DiaMedica Therapeutics' volatility.| Risk Adjusted Performance | 0.1222 | |||
| Jensen Alpha | 0.4897 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.158 | |||
| Treynor Ratio | 2.95 |
DiaMedica Therapeutics Backtested Returns
DiaMedica Therapeutics appears to be slightly risky, given 3 months investment horizon. DiaMedica Therapeutics secures Sharpe Ratio (or Efficiency) of 0.15, which denotes the company had a 0.15% return per unit of standard deviation over the last 3 months. By reviewing DiaMedica Therapeutics' technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please utilize DiaMedica Therapeutics' Downside Deviation of 2.5, semi deviation of 2.15, and Mean Deviation of 2.66 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, DiaMedica Therapeutics holds a performance score of 11. The firm shows a Beta (market volatility) of 0.17, which means not very significant fluctuations relative to the market. As returns on the market increase, DiaMedica Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding DiaMedica Therapeutics is expected to be smaller as well. Please check DiaMedica Therapeutics' mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and total risk alpha , to make a quick decision on whether DiaMedica Therapeutics' price patterns will revert.
Auto-correlation | 0.21 |
Weak predictability
DiaMedica Therapeutics has weak predictability. Overlapping area represents the amount of predictability between DiaMedica Therapeutics time series from 14th of December 2022 to 9th of December 2023 and 9th of December 2023 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DiaMedica Therapeutics price movement. The serial correlation of 0.21 indicates that over 21.0% of current DiaMedica Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.21 | |
| Spearman Rank Test | 0.36 | |
| Residual Average | 0.0 | |
| Price Variance | 0.51 |
DiaMedica Therapeutics lagged returns against current returns
Autocorrelation, which is DiaMedica Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting DiaMedica Therapeutics' stock expected returns. We can calculate the autocorrelation of DiaMedica Therapeutics returns to help us make a trade decision. For example, suppose you find that DiaMedica Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
DiaMedica Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If DiaMedica Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if DiaMedica Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in DiaMedica Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
DiaMedica Therapeutics Lagged Returns
When evaluating DiaMedica Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of DiaMedica Therapeutics stock have on its future price. DiaMedica Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, DiaMedica Therapeutics autocorrelation shows the relationship between DiaMedica Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in DiaMedica Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether DiaMedica Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DiaMedica Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Diamedica Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Diamedica Therapeutics Stock:Check out DiaMedica Therapeutics Correlation, DiaMedica Therapeutics Volatility and DiaMedica Therapeutics Alpha and Beta module to complement your research on DiaMedica Therapeutics. For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.